Loading...
Loading...
India's lenvatinib imports from TAIWAN total $180 across 2 shipments from 1 foreign suppliers. LOTUS PHARMACEUTICAL CO.LTD leads with $180 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include MSN LABORATORIES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for lenvatinib โ a concentrated sourcing relationship with select suppliers from TAIWAN.

LOTUS PHARMACEUTICAL CO.LTD is the leading Lenvatinib supplier from TAIWAN to India, with import value of $180 across 2 shipments. The top 5 suppliers โ LOTUS PHARMACEUTICAL CO.LTD โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | LOTUS PHARMACEUTICAL CO.LTD | $180 | 2 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MSN LABORATORIES PRIVATE LIMITED | $180 | 2 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Lenvatinib suppliers from TAIWAN to India include LOTUS PHARMACEUTICAL CO.LTD. The leading supplier is LOTUS PHARMACEUTICAL CO.LTD with import value of $180 USD across 2 shipments. India imported Lenvatinib worth $180 USD from TAIWAN in total across 2 shipments.
India imported Lenvatinib worth $180 USD from TAIWAN across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Lenvatinib sourced from TAIWAN include MSN LABORATORIES PRIVATE LIMITED. The largest buyer is MSN LABORATORIES PRIVATE LIMITED with $180 in imports across 2 shipments.
The total value of Lenvatinib imports from TAIWAN to India is $180 USD, across 2 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists